Pamuk ON et al. |
Are Turkish Helicobacter pylori strains gaining resistance against clarithromycin? |
2000 |
Am. J. Gastroenterol. |
pmid:10926000
|
Hammerschlag MR |
Treatment of Chlamydia pneumoniae. |
2000 |
Int. J. Antimicrob. Agents |
pmid:10926449
|
Nagaya T et al. |
A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome. |
2000 |
J. Clin. Invest. |
pmid:10930442
|
Van Oijen AH et al. |
Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930892
|
Hurenkamp GJ et al. |
Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930901
|
Lai KC et al. |
Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930902
|
Pilotto A et al. |
Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930903
|
Kihira K et al. |
Rabeprazole, amoxycillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930904
|
Kamada T et al. |
Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930905
|
Savarino V et al. |
OAM for cure of Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930908
|
Yamashita H et al. |
When can complete regression of low-grade gastric lymphoma of mucosa-associated lymphoid tissue be predicted after helicobacter pylori eradication? |
2000 |
Histopathology |
pmid:10931236
|
Gücüyener K et al. |
Methyl-prednisolone in neurologic complications of Mycoplasma pneumonia. |
2000 |
Indian J Pediatr |
pmid:10932970
|
Theron AJ et al. |
Investigation of the anti-inflammatory and membrane-stabilizing potential of spiramycin in vitro. |
2000 |
J. Antimicrob. Chemother. |
pmid:10933651
|
Kihara Y and Otsuki M |
Interaction of gliclazide and rifampicin. |
2000 |
Diabetes Care |
pmid:10937528
|
Morlet-Barla N et al. |
[Severe hypoglycemia and recurrence caused by disopyramide-clarithromycin interaction]. |
2000 Jul 8-15 |
Presse Med |
pmid:10938688
|
Narita N |
"Multi-effect" macrolides. |
2000 |
Intern. Med. |
pmid:10939528
|
Shivkumar K |
Images in cardiovascular medicine. Labile repolarization from "cell to bedside". |
2000 |
Circulation |
pmid:10942753
|
Kamochi H et al. |
Clarithromycin associated with torsades de pointes. |
1999 |
Jpn. Circ. J. |
pmid:10943628
|
Daudén E et al. |
Helicobacter pylori and idiopathic chronic urticaria. |
2000 |
Int. J. Dermatol. |
pmid:10944090
|
Sato K and Ebe T |
[A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease]. |
2000 |
Kekkaku |
pmid:10944891
|
Katz VL et al. |
Mycobacterium chelonae sepsis associated with long-term use of an intravenous catheter for treatment of hyperemesis gravidarum. A case report. |
2000 |
J Reprod Med |
pmid:10948471
|
Mayhew BS et al. |
An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation. |
2000 |
Drug Metab. Dispos. |
pmid:10950845
|
Boxenbaum H |
Human in vivo competitive inhibition of P450 substrates: increased plasma concentrations as a function of hepatic extraction ratio and percent inhibition. |
1999 Sep-Dec |
J Pharm Pharm Sci |
pmid:10953254
|
Gomollón F et al. |
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care]. |
2000 |
Med Clin (Barc) |
pmid:10953829
|
Piqué JM |
[Helicobacter pylori eradication in gastroduodenal ulcer: good, fine and not expensive]. |
2000 |
Med Clin (Barc) |
pmid:10953833
|
Fujiue Y et al. |
[Results of antimicrobial susceptibilities of strains clinically isolated at 8 institutions in Hiroshima City to major oral antimicrobial drugs, mainly new quinolone drugs. Hiroshima Levofloxacin Susceptibility Surveillance Group]. |
2000 |
Jpn J Antibiot |
pmid:10955237
|
Hatipoglu ON and Tasan Y |
A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia. |
2000 |
Yonsei Med. J. |
pmid:10957888
|
Dupas JL et al. |
[Acid suppression therapy is not required after one-week anti-Helicobacter pylori triple therapy for duodenal ulcer healing]. |
2000 Jun-Jul |
Gastroenterol. Clin. Biol. |
pmid:10962387
|
McCarty JM |
Clarithromycin in the management of community-acquired pneumonia. |
2000 |
Clin Ther |
pmid:10963284
|
Scaglione F et al. |
In vitro comparative dynamics of modified-release clarithromycin and of azithromycin. |
2000 Sep-Oct |
Chemotherapy |
pmid:10965100
|
Castellote J and Porta F |
[Combination of ranitidine and bismuth citrate plus 2 antibiotics in the eradication of Helicobacter pylori]. |
2000 |
Med Clin (Barc) |
pmid:10965489
|
Ozkan Y et al. |
Clarithromycin targeting to lung: characterization, size distribution and in vivo evaluation of the human serum albumin microspheres. |
2000 |
Farmaco |
pmid:10966162
|
Katsura Y et al. |
Anti-Helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives. |
2000 |
J. Med. Chem. |
pmid:10966750
|
Heep M et al. |
Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. |
2000 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10968325
|
Beyer G et al. |
Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microflora. |
2000 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10968328
|
Gisbert JP et al. |
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10971230
|
Frevel M et al. |
Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10971231
|
Colin AA |
Eradication of mycobacterium abscessus in a chronically infected patient with cystic fibrosis. |
2000 |
Pediatr. Pulmonol. |
pmid:10973047
|
Cattoli G et al. |
Helicobacter acinonychis eradication leading to the resolution of gastric lesions in tigers. |
2000 |
Vet. Rec. |
pmid:10975334
|
Scuderi G et al. |
Helicobacter pylori: use of a stool antigen detection test and a six-day triple therapy. |
2000 Jan-Feb |
Dig Liver Dis |
pmid:10975761
|
Buzás György M et al. |
[Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer]. |
2000 |
Orv Hetil |
pmid:10976194
|
Sohn YT et al. |
Polymorphism of clarithromycin. |
2000 |
Arch. Pharm. Res. |
pmid:10976587
|
Bosne-David S et al. |
Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors. |
2000 |
J. Antimicrob. Chemother. |
pmid:10980165
|
Denis A et al. |
Beta-keto-ester chemistry and ketolides. Synthesis and antibacterial activity of 2-halogeno, 2-methyl and 2,3 enol-ether ketolides. |
2000 |
Bioorg. Med. Chem. Lett. |
pmid:10987440
|
Komine M and Tamaki K |
An open trial of oral macrolide treatment for psoriasis vulgaris. |
2000 |
J. Dermatol. |
pmid:10989574
|
Hentschel E |
[Treatment of Helicobacter pylori infections]. |
2000 |
Acta Med. Austriaca |
pmid:10989677
|
Bermudez LE et al. |
Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991834
|
Ohtani H et al. |
Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991836
|
Rastogi N et al. |
In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991870
|
Cynamon MH et al. |
Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991883
|
Howden CW |
Treatment of Helicobacter pylori infection: is less more? |
2000 |
J. Clin. Gastroenterol. |
pmid:10993423
|
Catalano F et al. |
Five-day triple therapy in Helicobacter pylori-positive duodenal ulcer: an eighteen-month follow-up. |
2000 |
J. Clin. Gastroenterol. |
pmid:10993428
|
Testoni PA and Bagnolo F |
In dyspeptic patients without gastric phase III of the migrating motor complex, Helicobacter pylori eradication produces no short-term changes in interdigestive motility pattern. |
2000 |
Scand. J. Gastroenterol. |
pmid:10994618
|
Mushiroda T et al. |
The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate. |
2000 |
Drug Metab. Dispos. |
pmid:10997945
|
Huang AH et al. |
Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy. |
2000 |
J. Formos. Med. Assoc. |
pmid:11000734
|
Shimizu T et al. |
Case of intrafamilial Helicobacter pylori reinfection after successful eradication therapy. |
2000 |
Pediatr. Infect. Dis. J. |
pmid:11001123
|
Bermejo F et al. |
[Effects of Helicobacter pylori eradication on the recurrence of gastric ulcer during a 12-month follow up]. |
2000 |
Med Clin (Barc) |
pmid:11002456
|
Gisbert JP et al. |
Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11012477
|
Catalano F et al. |
Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11012478
|
Gomollón F et al. |
Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11012479
|
Westphal JF |
Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin. |
2000 |
Br J Clin Pharmacol |
pmid:11012550
|
Yanagihara K et al. |
Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa. |
2000 |
Clin. Exp. Immunol. |
pmid:11012620
|
Alter P et al. |
[Impediment of cellular immune response under treatment with ticlopidine in a patient with Staphylococcus aureus endocarditis]. |
2000 |
Z Kardiol |
pmid:11013974
|
Makristathis A et al. |
Two enzyme immunoassays and PCR for detection of Helicobacter pylori in stool specimens from pediatric patients before and after eradication therapy. |
2000 |
J. Clin. Microbiol. |
pmid:11015388
|
Wolfe J et al. |
Mycobacterium branderi from both a hand infection and a case of pulmonary disease. |
2000 |
J. Clin. Microbiol. |
pmid:11015432
|
Saint-Blancard P et al. |
[Cutaneous nodular infection with hemopathy]. |
2000 |
Ann Pathol |
pmid:11015652
|
Lamouliatte H et al. |
[Treatment of Helicobacter pylori infection]. |
2000 |
Rev Prat |
pmid:11019637
|
Kuper JI and D'Aprile M |
Drug-Drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease. |
2000 |
Clin Pharmacokinet |
pmid:11020135
|
Cirioni O et al. |
Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline. |
2000 |
J. Antimicrob. Chemother. |
pmid:11020255
|
Alarcón T et al. |
Clarithromycin resistance stability in Helicobacter pylori: influence of the MIC and type of mutation in the 23S rRNA. |
2000 |
J. Antimicrob. Chemother. |
pmid:11020260
|
Guyot A et al. |
Clarithromycin appears to be linked with Clostridium difficile-associated diarrhoea in the elderly. |
2000 |
J. Antimicrob. Chemother. |
pmid:11020269
|
Cammarota G et al. |
Six-day therapy with ranitidine bismuth citrate plus low-dose clarithromycin and tinidazole to cure Helicobacter pylori infection. |
2000 Jul-Aug |
Hepatogastroenterology |
pmid:11020908
|
Umegaki N et al. |
Clarithromycin-resistance and point mutations in the 23S rRNA gene in Helicobacter pylori isolates from Japan. |
2000 |
J. Gastroenterol. Hepatol. |
pmid:11022832
|
Goh K et al. |
Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients. |
2000 |
J. Gastroenterol. Hepatol. |
pmid:11022833
|
Giacometti A et al. |
Combination studies between polycationic peptides and clinically used antibiotics against Gram-positive and Gram-negative bacteria. |
2000 |
Peptides |
pmid:11035200
|
Giacometti A et al. |
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics. |
2000 |
Diagn. Microbiol. Infect. Dis. |
pmid:11035243
|
Rea TH |
Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy. |
2000 |
Int. J. Lepr. Other Mycobact. Dis. |
pmid:11036492
|
McWhinney PH et al. |
Failure to produce detectable antibodies to Legionella pneumophila by an immunocompetent adult. |
2000 |
J. Infect. |
pmid:11041710
|
Frank F et al. |
Helicobacter pylori infection in recurrent abdominal pain. |
2000 |
J. Pediatr. Gastroenterol. Nutr. |
pmid:11045841
|
Kelley MA et al. |
Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. |
2000 |
Clin. Infect. Dis. |
pmid:11049784
|
Giannini E et al. |
Influence of Helicobacter pylori eradication therapy on 13C aminopyrine breath test: comparison among omeprazole-, lansoprazole-, or pantoprazole-containing regimens. |
2000 |
Am. J. Gastroenterol. |
pmid:11051345
|
Bhasin DK et al. |
Drug resistance in Helicobacter pylori infection. |
2000 |
Indian J Gastroenterol |
pmid:11060974
|
Edlund C et al. |
Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora. |
2000 |
J. Antimicrob. Chemother. |
pmid:11062193
|
Seppälä K et al. |
Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients. |
2000 |
Scand. J. Gastroenterol. |
pmid:11063151
|
Chow LW et al. |
Clarithromycin attenuates mastectomy-induced acute inflammatory response. |
2000 |
Clin. Diagn. Lab. Immunol. |
pmid:11063500
|
Herr H and You CH |
Relationship between Helicobacter pylori and rosacea: it may be a myth. |
2000 |
J. Korean Med. Sci. |
pmid:11068993
|
Wong BC et al. |
Triple therapy with clarithromycin, omeprazole, and amoxicillin for eradication of Helicobacter pylori in duodenal ulcer patients in Asia and Africa. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:11069326
|
Dunne M et al. |
A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus. |
2000 |
Clin. Infect. Dis. |
pmid:11073759
|
Delgado M et al. |
[Cavitating pneumonia in a patient infected with human immunodeficiency virus]. |
2000 Jun-Jul |
Enferm. Infecc. Microbiol. Clin. |
pmid:11075487
|
Krebs T et al. |
Mycobacterium genavense infection in a patient with long-standing chronic lymphocytic leukaemia. |
2000 |
J. Intern. Med. |
pmid:11086646
|
Ferrero M et al. |
Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period. |
2000 |
Int. J. Antimicrob. Agents |
pmid:11091043
|
Yoshida H et al. |
Reversal of intra-amniotic Chlamydia trachomatis antigen status. |
2000 |
Gynecol. Obstet. Invest. |
pmid:11093054
|
Knower MT et al. |
Clarithromycin for safe and cost-effective reduction of cyclosporine doses in lung allograft recipients. |
2000 |
South. Med. J. |
pmid:11095559
|
Lucas J et al. |
Mycobacterium genavense infection in two aged ferrets with conjunctival lesions. |
2000 |
Aust. Vet. J. |
pmid:11098383
|
Witthaut J and Möhlen S |
[Chronic paronychia and synovialitis of extensor tendons due to Mycobacterium marinum. Is diagnosis or treatment the problem?]. |
2000 |
Handchir Mikrochir Plast Chir |
pmid:11103693
|
Lerro P et al. |
CagA seropositivity and the severity of Helicobacter pylori infection in dyspeptic children. |
2000 |
Acta Paediatr. |
pmid:11106041
|
Fock KM |
Clarithromycin resistance in Helicobacter pylori infection: does it matter? |
2000 |
J. Gastroenterol. Hepatol. |
pmid:11106085
|
Hamada H et al. |
[A case of pneumonia caused by Mycobacterium avium complex successfully treated with clarithromycin]. |
2000 |
Nihon Ronen Igakkai Zasshi |
pmid:11109848
|
Warner A |
Clarithromycin--a precipitant for acute psychotic stress. |
2000 Nov-Dec |
Psychosomatics |
pmid:11110120
|
Hunt RH et al. |
Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group. |
2000 |
Can. J. Gastroenterol. |
pmid:11111109
|